Meril Life Sciences

Meril Life Sciences is an Indian multinational medical device manufacturer with global reach across more than 100 countries. The company develops and markets innovative cardiovascular devices—including India’s first domestically produced bioresorbable scaffold—orthopedic implants for joint replacement surgery, advanced diagnostic kits for infectious diseases and chronic conditions such as diabetes management. Its COVID‑19 rapid antigen test “CoviFind” was among the first approved self-use tests during the pandemic. The pipeline includes over thirty new medical devices under development across cardiovascular intervention and orthopedics. Clinical results have established several flagship products as safe and effective within their intended uses.